Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Room-temperature mid-infrared sensors using colloidal quantum dots (MIRDOT)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: United Kingdom
Call: MSCA Postdoctoral Fellowships 2024 (HORIZON-MSCA-2024-PF-01, 2024)
Start date: 2026-09-01
End date: 2028-08-31
Duration (months): 24.0
Total project cost (EUR): 276187.92
EU funding (EUR): 276187.92
Participants: 1
Project status: SIGNED

Mid-infrared (MIR) sensors are pivotal in enabling a broad range of applications, including environmental monitoring, medical imaging, safety, and food analysis. The current sensing technologies within this spectral range (λ= 3-30 μm) rely on high-cost and complex fabrications of epitaxially grown semiconductors. These sensors are not monolithic to silicon photonics and require cryogenic operating temperatures, limiting their adoption to the market. Alternatively, colloidal quantum dots (CQD) offer unique properties for sensing MIR light, including low-cost production, ease of processing, and silicon CMOS compatibility. The MIRDOT project will develop room-temperature (RT), cost-effective, and high-performance MIR sensors using CQD. So far, CQD technology has revolutionized the optoelectronics industry, particularly through the development of advanced sensors such as PbS CQD near-infrared (NIR) image sensors. These sensors leverage interband transitions in CQD, limiting their sensitivity to the NIR region. Intraband transitions in CQD, however, enable access to MIR region. Previously, doped PbS and HgTe CQDs have been investigated for MIR detection through intraband absorption. Nevertheless, these detectors exhibit extremely poor sensitivity at RT due to structural constraints and background noise in the MIR. In this project, I propose to effectively address these limitations by upconverting MIR radiation to NIR emission, enabling reliable detection with standard silicon detectors at RT. In this project, I will develop CQD-MIR sensors by coupling doped PbS(Se) CQD with extreme plasmonic nanocavities under optical pumping. To integrate these sensors with CMOS technology, I will design and fabricate electrically-driven sensors. Finally, as proof-of-concept phase, I aim to develop MIR imaging and gas sensors that operate at RT using these CQD-MIR sensors. The MIRDOT project will extend CQD technology into new spectral regions, greatly advancing future technologies.

Keywords: plasmonic nanocavities,colloidal quantum dots,lead chalcogenide,doping,intraband absorption,infrared radiation,mid infrared,upconversion,photodetectors,cmos technology,silicon photonics
Formation of Degradable Photoantimicrobial Materials via Light Induced 3D Printing (PhotoAntiMic3DP)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Germany
Call: MSCA Postdoctoral Fellowships 2023 (HORIZON-MSCA-2023-PF-01, 2023)
Start date: 2024-09-01
End date: 2026-08-31
Duration (months): 24.0
Total project cost (EUR): 189687.36
EU funding (EUR): 189687.36
Participants: 1
Project status: SIGNED

It has been an ongoing requirement for humankind to access useful objects or to provide the missing part of damaged products. 3D printing (3DP) has become popular by completing these deficiencies in a very short time and low cost. Its many derivatives are available, however, it is a necessity to choose suitable modules and inks that fulfill the needs of in today’s world. Energy consumption of the world is increasing rapidly and this concept should be carefully considered in every step to be taken from social life to industrial life. Thus, light-induced 3D printing (L3DP) stands out with its features such as using clean energy source, high resolution and accuracy. Nonetheless, substantial effort is necessary to identify and put into action suitable photochemical interactions for this objective. Significantly, the selection of these interactions must be carried out carefully since the resulting materials should meet other contemporary demands; such as Recyclability. Dibenzazapine (DBA) and triazolinedione (TDA) are important molecules capable of giving light-induced reactions. Their reversible reactions with light and buffer solutions offer them the advantage to form degradable products and they can be promising candidates for L3DP. On the other hand, following the impact of COVID-19, the medical industry has reached a pivotal moment where the significance of antimicrobial materials has been better understood. However, the developed materials cannot keep up with the resistance rate of microbes and different combat strategies are necessity to cope with them. Antimicrobial photodynamic therapy (aPDT) is method which is utilized the interaction between photosensitizer (PS) and light, and it can be strong alternative for this purpose. In this context; zinc phthalocyanine as photosensitizier will be incorporated into 3D materials to obtain degradable photoantimicrobial properties thanks to DBA and TAD photochemical reactions.

Keywords: light induced 3d printing,photodynamic antimicrobial therapy,phthalocyanine,dibenzazepine,triazolinedion
SUStainable Antimicrobial and Antiviral Nanocoating (SUSAAN)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Digital, Industry and Space
Theme: Industry
Destination: Increased Autonomy in Key Strategic Value Chains for Resilient Industry
Action type: Research and Innovation actions
Countries involved: Spain,Greece,Germany,Belgium,Türkiye,Italy,France
Call: Antimicrobial, Antiviral, and Antifungal Nanocoatings (RIA) (HORIZON-CL4-2021-RESILIENCE-01, 2021)
Start date: 2022-06-01
End date: 2025-11-30
Duration (months): 42.0
Total project cost (EUR): 5754846.25
EU funding (EUR): 5754843.0
Participants: 14
Project status: SIGNED

Infectious diseases pose a significant threat to both human health and the global economy, they account for more than 20% of global mortality and viruses are responsible for about one-third of these deaths. To date, we know of about 200 infectious diseases and about 80% of infectious diseases are transmitted by unclean hands touching contaminated surfaces. SUSAAN project is focussed on development of new sustainable antiviral and antimicrobial coatings for textiles and high traffic objects made of plastics and metal, involving textile, bathrooms and switches manufacture industries. In this context, it can be stated that most of the common hand-touch sites and/or objects are covered by the project so final impact would be extensive after the successful project execution, being the results of the project validated in three main market sectors through end users. Consortium Partners and core business are one of the strongest points of SUSAAN. Technological and scientific partners (LUREDERRA, NCSRD, IVW, CEIT and ITENE) are experts on main areas of nanoparticles, coatings, pretreatment, biobased nanocapsules and toxicity assessment. Companies involved cover the whole value change based on their core business including coatings production (TECNAN), biobased products (CELABOR), bathrooms manufacturing (ECZACIBASI), home appliances (PANASONIC) and textiles (ALMAXTEX). Last but not least, INTER IT will cover the activities on BPR assessment being VIRHEALTH (the expert on virology) on charge of standardized testing to determine virucidal and antimicrobial activity of the coatings and ARDITEC on charge of sustainability assessment. The final outcome of SUSAAN project is the validation of the new sustainable antimicrobial/antiviral nanocoating in different final products: high traffic objects (plastic and metallic) and textiles. Technical advantages and comparative results to current solutions will be used to present SUSAAN solutions to potential clients.

Keywords: nanoparticles,metaloxide nanoparticles,antimicrobial,antiviral,sustainable synthesis,toxicity,durability
Acting Out Disease. How Patient Organizations Shaped Modern Medicine (ActDisease)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: The Study of the Human Past
Panel description: Archaeology and history
Countries involved: Sweden
Call: ERC STARTING GRANTS (ERC-2021-STG, 2021)
Start date: 2023-01-01
End date: 2027-12-31
Duration (months): 60.0
Total project cost (EUR): 1499773.0
EU funding (EUR): 1499773.0
Participants: 1
Project status: SIGNED

This project will provide crucial insights into the development of modern medicine and the role of lay involvement in science through analysis of so far largely neglected, but central actors in 20th century medical history: patient organizations. These groups first emerged in the late 19th century, and worked towards increased attention to particular illnesses, shared information on disease management, promoted treatments, and developed healthcare resources. This project is the first historical analysis of these early patient organizations' role in shaping ideas about illness and medical practices, and the first systematic account of how disease became an object of civic organization. It will argue that modern medicine was to a significant degree shaped by organized patients, who helped establish disease concepts and associated practices - and that this deep involvement of patients in medicine facilitated an extended reach of medical power which resonates in contemporary society. It will also investigate how patients, in acting out medical knowledge, assumed notions of selfhood that overlapped and interacted with those of medical scientists. I will lead a team of researchers to analyse the publications and archives of patient organizations from four European nations - Sweden, Germany, United Kingdom and France - a vast source material previously not considered by historians. Studying these rich sources will answer some of the core questions related to medicine in the 20th century, and in particular the role of patients: How was the idea of diseases as distinct entities established, how has it changed the medical landscape and the way we regard ourselves in relation to health and illness? What was the role of patients themselves in this transformative process, how has their involvement in knowledge generation and decision-making developed over the past century, and to what extent has it lived up to the hopes of being a democratizing force in medicine?

Keywords: history of medicine,patient history,patient organizations,history of knowledge,lay knowledge
Bridging Research and Industry for the Development of Ground-breaking air-breathing Electric propulsion (BRIDGE)

Framework: Horizon Europe — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Proof of concept grants
Action type: ERC actions
Countries involved: Italy
Call: ERC PROOF OF CONCEPT GRANTS (ERC-2025-POC, 2025)
Start date: 2025-11-01
End date: 2027-04-30
Duration (months): 18.0
Total project cost (EUR): 150000.0
EU funding (EUR): 150000.0
Participants: 1
Project status: SIGNED

Air-breathing electric propulsion (ABEP) offers a game-changing alternative to conventional spacecraft propulsion by using atmospheric particles as propellant, enabling sustained operations in very low Earth orbit (VLEO). This region of space provides advantages like higher spatial resolution and reduced latency, but atmospheric drag drastically shortens satellite lifetimes. ABEP can overcome this challenge, extending mission duration without the need of onboard propellant. BRIDGE aims to leverage the testing, analysis, and insights developed in the BREATHE ERC project to advance a promising early-stage air-breathing electric propulsion technology, based upon a combination of microwave power and novel magnetic field topologies to achieve high ionization efficiency at very-low pressures. The key objectives of BRIDGE are: (i) optimizing the trade-off between atmospheric propellant collection and ionization, and (ii) demonstrating the concept functionality on-ground and extrapolating performance to flight conditions, and (iii) developing a roadmap for in-orbit demonstration and commercialization of the technology, paving the way for cost-effective and sustainable VLEO space assets with broad scientific and commercial applications.

Keywords: air breathing electric propulsion,plasma physics,very low earth orbit,cubesat,atmosphere,space propulsion
Hydrogen Solutions for euroPean Airports & Regional Kinetics (HySPARK)

Framework: Horizon Europe — Global Challenges and European Industrial Competitiveness
Programme: Climate, Energy and Mobility
Theme: Public-private partnerships
Destination: Clean Hydrogen
Action type: Innovation actions
Partnership: CLEANH2 (JU-JTI)
Countries involved: Poland,United Kingdom,Italy,Ireland
Call: Small-scale Hydrogen Valley (HORIZON-JTI-CLEANH2-2024, 2024)
Start date: 2025-01-01
End date: 2029-12-31
Duration (months): 60.0
Total project cost (EUR): 11674025.0
EU funding (EUR): 8999074.63
Participants: 15
Project status: SIGNED

Hydrogen's importance globally is evident across multiple sectors like industry, energy, and transport, with the EU prioritizing renewable hydrogen production. Strategies outlined in the EU Hydrogen Strategy and REPowerEU plan aim to decarbonize the EU and reduce reliance on imported fossil fuels. The shift towards hydrogen requires comprehensive strategies, encompassing investment support, market creation, and global cooperation. HySPARK in Poland accelerates this transition by overcoming technological and non-technological barriers. With a production hub in Włocławek, it aims to produce over 3,000 tons of renewable hydrogen annually, serving various local applications. Six testbed applications will be tested for at least 2 years, gathering operational data to evaluate the techno-economic, societal, and environmental metrics. The testbeds will cover both the transport and the industry sectors and will consist of: (i) the upstream hydrogen production and (ii) the Hydrogen Refuelling stations infrastructure; (iii) 4 semi-trucks for freight road, (iv) 2 buses for the public road, (v) 8 tow tractors for the ground handling transport; (vi) Green Ammonia production. Each testbed application will be fully set up in terms of infrastructure, planning of the associated logistics and the synergetic management of all distributed assets, to demonstrate the practicality and efficiency of H2, also integrated within Warsaw Chopin Airport to contribute to EU's 2050 hydrogen-ready airports objective. Nevertheless, HySPARK will develop the user-friendly and intuitive Energy Planner utilized to refine and optimize the HySPARK supply chain, ensuring its seamless integration into the broader energy ecosystem. In connection with ongoing EU-funded projects (TH2ICINO and SH2AMROCK), HySPARK leverages established networks to improve project deliverables and fosters a community of practice that supports continuous improvement and innovation in hydrogen valley initiatives.

Keywords: mazovian hydrogen valley,w oc awek production hub,green ammonia,clean mobility,green industry,warsaw airport,hydrogen production,freight and public road transport,ground handling transport
The world’s most sensitive absorption microscope (QlibriNANO)

Framework: Horizon Europe — Innovative Europe
Programme: The European Innovation Council (EIC)
Theme: EIC Transition
Destination: Open to supporting projects in all areas of science, technology,...
Action type: EIC actions
Countries involved: Germany
Call: EIC Transition Open 2023 (HORIZON-EIC-2023-TRANSITION-01, 2023)
Start date: 2024-07-01
End date: 2027-06-30
Duration (months): 36.0
Total project cost (EUR): 2480000.0
EU funding (EUR): 2480000.0
Participants: 1
Project status: SIGNED

QlibriNANO is the world’s most sensitive absorption microscope (1,000 times more sensitive than state-of-the-art), enabling the detection, imaging, characterization, understanding and development of nanoscale matter on a new level by its unique combination of fast and ultrasensitive hyperspectral imaging. QlibriNANO gives access to a so-far inaccessible area of information relevant for research fields like nanoparticles, optical coatings, thin films, among others, making the invisible visible for the first time. Our innovation rests on the usage of an optical microresonator instead of a conventional objective. We have untapped this possibility, since Qlibri has developed a breakthrough fabrication method of micromirrors based on a semiconductor quantum cascade laser system. This proprietary method has allowed Qlibri to become the first company in the world to commercialize micromirrors, a key component for our first-of-its-kind resonator microscope. Qlibri’s unique blend of expertise, combining a profound know-how in microresonators and deep understanding of microscopy, particularly raster scanning techniques, has made it possible to make a technology transfer from Quantum optics to optical microscopy to develop QlibriNANO. The great market potential of our disruptive resonator microscope has been confirmed by more than 20 prospective customers. This EIC Transition project has the objective of validating the product-market fit for the nanotechnology and optical coatings markets, improving the technical requirements (mostly fast spectroscopy) of our system as well as the usability, and validating these technological improvements with end users in these sectors (TRL 6). Moreover, we aim to improve the manufacturability of QlibriNANO, and ensure a cost-efficient, scalable and reliable manufacturing. Upon accomplishment of these objectives, Qlibri will be in a good position to raise the necessary funds to tackle the TRL 7-9 activities and reach the market by 2027.

Keywords: absorption microscope,optical resonator,micromirrors,spectral characterization,real time imaging,nanotechnology,hyperspectral imaging
UltrAfast correLated Two-dimensional mOiré Superlattices (ALTOS)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Finland,Spain
Call: MSCA Postdoctoral Fellowships 2023 (HORIZON-MSCA-2023-PF-01, 2023)
Start date: 2024-08-01
End date: 2026-07-31
Duration (months): 24.0
Total project cost (EUR): 215534.4
EU funding (EUR): 215534.4
Participants: 2
Project status: SIGNED

As one of the most fascinating phenomena in physics, strong correlation exists across a wide range of scales from planet to electron. Researchers have been pursuing a thorough understanding of strong-correlation phenomena for decades. In addition to the equilibrium correlated states detected by electric methods, nonequilibrium correlated dynamics that reveals more fingerprints of many-body interaction at a transient timescale is also significant. The emergence of two-dimensional (2D) moiré superlattices provides an excellent platform to probe localized nonequilibrium correlation phenomena by ultrafast laser excitation and spectroscopic detection with high resolution in both space and time. The combination of large moiré lattices in space and femtosecond-scale resolution in time will offer us a powerful tool to unravel the signature of unconventional dynamics of strong-correlated states, which not only deepens our understanding of complex quantum systems but also holds promise for the development of advanced technologies with transformative applications in fields like quantum computing and energy transmission. This interdisciplinary training scheme aims to enhance Dr. Shang’s expertise in photonics, strengthening his skills and helping him establish a research career in Europe. The program covers component design and implementation, theoretical analysis and photonics experiments. To assist Shang in reaching professional maturity and increase his exposure to academic and industrial collaborations, he will receive training on intellectual property management, funding and proposal writing, commercialization, business and finance management, supervision, and teaching. Additionally, Shang will have the opportunity to establish cooperation with Prof. Abajo (ICFO, Spain) as part of an academic secondment. This will maximize his learning experience, expand his network in Europe, and maximize the impact of research and training on EU society and industry.

Keywords: ultrafast dynamics,strong correlation,two dimensional materials,ultrafast spectroscopy,nonlinear optics
Modelling of Epithelial-to-Mesenchymal Transition in Invading Cells (METrIC)

Framework: Horizon Europe — Excellent Science
Programme: Marie Skłodowska-Curie Actions (MSCA)
Theme: Marie Skłodowska-Curie
Destination: Postdoctoral Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Mathematics
Countries involved: United Kingdom
Call: MSCA Postdoctoral Fellowships 2024 (HORIZON-MSCA-2024-PF-01, 2024)
Start date: 2025-09-01
End date: 2027-08-31
Duration (months): 24.0
Total project cost (EUR): 260347.92
EU funding (EUR): 260347.92
Participants: 1
Project status: CLOSED

Cell migration is at the core of many biological processes in development and cancer progression. Epithelial-to-mesenchymal transition (EMT), i.e. the temporary and reversible switching between epithelial and mesenchymal phenotypes, plays a crucial role in increasing the motility and invasiveness of cells, representing a potential therapeutic target in many biomedical areas. With the surge of omics data, we are now more than ever able to characterise the phenotypic properties of cells and require theoretical frameworks which can effectively integrate such information to help us predict tissue-level behaviours for optimisation of therapeutic interventions. My project is devoted to the development of such a theoretical framework, in which cell migration through the extracellular matrix (ECM) is mediated by the cell phenotypic state which may change guided by mechanistic rules for EMT, incorporating information on the cell phenotypic state coming from omics data. I will focus on mathematical models comprising nonlocal partial differential equations of the evolutionary dynamics of space- and phenotype-structured cell populations. By representing cell phenotypes on a continuum, the models can capture intratumour heterogeneity and hybrid phenotypes, and may be directly linked with transcriptomic and proteomic data. This project will tackle the analytical and numerical challenges stemming from movement in physical space, modelling heterogeneous cell motion in the ECM, and complex phenotypic drifts, incorporating a description of core regulatory circuits for EMT, yet to be investigated in a unified framework. Moreover, we will address the inverse problem of employing transcriptomic data to infer the nonlinear impact of environmental factors on the core regulatory circuit mediating phenotypic changes, to this day an open problem. The outcomes of the project will advance mathematical, biomedical and interdisciplinary research.

Keywords: mathematical models nonlocal partial differential equations asymptotic analysis numerical simulations data integration phenotypic adaptation cancer invasion epithelial to mesenchymal transition